These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27597124)

  • 1. Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
    Contreras-Sanz A; Roberts ME; Seiler R; Black PC
    Int J Urol; 2017 Jan; 24(1):7-15. PubMed ID: 27597124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
    Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
    Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer.
    Chedgy EC; Douglas J; Wright JL; Seiler R; van Rhijn BW; Boormans J; Todenhöfer T; Dinney CP; Collins CC; Van der Heijden MS; Black PC
    Urol Oncol; 2016 Oct; 34(10):469-76. PubMed ID: 27317490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
    Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
    J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.
    Birkenkamp-Demtröder K; Christensen E; Nordentoft I; Knudsen M; Taber A; Høyer S; Lamy P; Agerbæk M; Jensen JB; Dyrskjøt L
    Eur Urol; 2018 Apr; 73(4):535-540. PubMed ID: 28958829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility versus futility: a tipping point for liquid biopsies in bladder cancer.
    Kouba E; Cheng L
    Future Oncol; 2019 Nov; 15(33):3751-3753. PubMed ID: 31651200
    [No Abstract]   [Full Text] [Related]  

  • 7. Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology.
    Dyrskjøt L; Ingersoll MA
    Curr Opin Urol; 2018 Nov; 28(6):598-603. PubMed ID: 30138123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
    Christensen E; Birkenkamp-Demtröder K; Nordentoft I; Høyer S; van der Keur K; van Kessel K; Zwarthoff E; Agerbæk M; Ørntoft TF; Jensen JB; Dyrskjøt L
    Eur Urol; 2017 Jun; 71(6):961-969. PubMed ID: 28069289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.
    Hahn AW; Stenehjem D; Nussenzveig R; Carroll E; Bailey E; Batten J; Maughan BL; Agarwal N
    Cancer Treat Res Commun; 2019; 19():100120. PubMed ID: 30743187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response Prediction.
    Yang Y; Miller CR; Lopez-Beltran A; Montironi R; Cheng M; Zhang S; Koch MO; Kaimakliotis HZ; Cheng L
    Crit Rev Oncog; 2017; 22(5-6):389-401. PubMed ID: 29604919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.
    Teo MTW; Dyrskjøt L; Nsengimana J; Buchwald C; Snowden H; Morgan J; Jensen JB; Knowles MA; Taylor G; Barrett JH; Borre M; Ørntoft TF; Bishop DT; Kiltie AE
    Ann Oncol; 2014 Apr; 25(4):877-883. PubMed ID: 24623370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Introduction and Clinical Application of Cell-Free Tumor DNA.
    Li J; Liu R; Huang C; Chen S; Xu M
    Methods Mol Biol; 2018; 1754():45-65. PubMed ID: 29536437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual.
    Koessler T; Addeo A; Nouspikel T
    Adv Clin Chem; 2019; 89():131-188. PubMed ID: 30797468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
    Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolution of bladder cancer genomics: What have we learned and how can we use it?
    Audenet F; Attalla K; Sfakianos JP
    Urol Oncol; 2018 Jul; 36(7):313-320. PubMed ID: 29573965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular limitations of biomarker research in bladder cancer.
    Vlachostergios PJ; Faltas BM
    World J Urol; 2019 May; 37(5):837-848. PubMed ID: 30171455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interest of next-generation sequencing in BCG-treated high-risk bladder cancer.
    Jungels C; Martinez Chanza N; Albisinni S; Mercier M; d'Haene N; Rorive S; Roumeguère T
    Prog Urol; 2018 May; 28(6):344-350. PubMed ID: 29673906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?
    Bruchbacher A; Soria F; Hassler M; Shariat SF; D'Andrea D
    Curr Opin Urol; 2018 Nov; 28(6):584-590. PubMed ID: 30188332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.